These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24477050)

  • 21. Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.
    Deplanque D; Leys D; Parnetti L; Schmidt R; Ferro J; de Reuck J; Mas JL; Gallai V;
    Cerebrovasc Dis; 2006; 21(5-6):372-9. PubMed ID: 16490950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.
    Maeder MT; König T; Bogdanovic S; Schneider I; Eugster W; Ammann P; König M; Beer J; Rickli H
    Swiss Med Wkly; 2017; 147():w14503. PubMed ID: 29039622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.
    Løkkegaard T; Pedersen TH; Lind B; Siersma V; Waldorff FB
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
    Ramakumar V; Benz AP; Karthikeyan G
    Indian Heart J; 2021; 73(2):244-248. PubMed ID: 33865530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    O'Brien EC; Holmes DN; Ansell JE; Allen LA; Hylek E; Kowey PR; Gersh BJ; Fonarow GC; Koller CR; Ezekowitz MD; Mahaffey KW; Chang P; Peterson ED; Piccini JP; Singer DE
    Am Heart J; 2014 Apr; 167(4):601-609.e1. PubMed ID: 24655711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment is not a predictor of failure to adhere to anticoagulation of stroke patients with atrial fibrillation.
    Horstmann S; Rizos T; Saribas M; Efthymiou E; Rauch G; Veltkamp R
    Cerebrovasc Dis; 2015; 39(5-6):325-31. PubMed ID: 25966900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.
    Jones M; McEwan P; Morgan CL; Peters JR; Goodfellow J; Currie CJ
    Heart; 2005 Apr; 91(4):472-7. PubMed ID: 15772203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B; Masuhr F; Weih M
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial.
    Claes N; Buntinx F; Vijgen J; Arnout J; Vermylen J; Fieuws S; Van Loon H
    Eur Heart J; 2005 Oct; 26(20):2159-65. PubMed ID: 15917280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Update on the control of patients on treatment with vitaminK antagonist oral anticoagulants in Primary Care].
    Fernández López P; López Ramiro MI; Merino de Haro I; Cedeño Manzano G; Díaz Siles FJ; Hermoso Sabio A
    Semergen; 2016; 42(8):530-537. PubMed ID: 26877111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
    Wallentin L; Lopes RD; Hanna M; Thomas L; Hellkamp A; Nepal S; Hylek EM; Al-Khatib SM; Alexander JH; Alings M; Amerena J; Ansell J; Aylward P; Bartunek J; Commerford P; De Caterina R; Erol C; Harjola VP; Held C; Horowitz JD; Huber K; Husted S; Keltai M; Lanas F; Lisheng L; McMurray JJ; Oh BH; Rosenqvist M; Ruzyllo W; Steg PG; Vinereanu D; Xavier D; Granger CB;
    Circulation; 2013 Jun; 127(22):2166-76. PubMed ID: 23640971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.
    Poli D; Antonucci E; Marcucci R; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D
    Int J Cardiol; 2009 Feb; 132(1):109-13. PubMed ID: 18180057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study.
    Costa GL; Lamego RM; Colosimo EA; Valacio RA; Moreira Mda C
    Clin Ther; 2012 Jul; 34(7):1511-20. PubMed ID: 22717417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quality of long-term oral anticoagulation: an observation study].
    Turk A; Sidler P; Bühler H; Christen S
    Praxis (Bern 1994); 2003 Oct; 92(42):1769-73. PubMed ID: 14598533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the quality of long-term anticoagulation therapy with antivitamin-K in atrial fibrillation].
    Ben Rejeb O; Brahim W; Ghali H; Ernez S; Mahdhaoui A; Jeridi G
    Ann Cardiol Angeiol (Paris); 2019 Apr; 68(2):80-86. PubMed ID: 30293798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
    Rose AJ; Hylek EM; Berlowitz DR; Ash AS; Reisman JI; Ozonoff A
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):276-82. PubMed ID: 21505156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A consultant-led anticoagulation review of all patients in one clinical commissioning group to prevent atrial fibrillation related stroke.
    Grayson AD; Garnett F; Davies M; Connor N; Hughes C; Cooper JP
    Int J Clin Pract; 2020 Apr; 74(4):e13465. PubMed ID: 31854038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.